While significant advances continue to be made with the identification of blood-based biomarkers for AD, there is an emergent interest in the use of ocular imaging or other ocular biomarkers as a parallel approach in the early detection of the disease. To meet this need, NDRI’s Human Tissue and Organs for Research Resource (HTORR) Program was recently expanded via an administrative supplemental grant from the National Institute on Aging (NIA) to support Alzheimer’s Disease and AD-related dementia (AD/ADRD) studies that require both ocular and other tissues for their experimental analysis.
The OTRAD program can tailor the acquisition of both ocular and other tissue samples to meet the specific needs of each research project. OTRAD can provide tissue types for a wide range of experimental needs. This includes:
**ocular tissues and brain, ocular histological sections